Natalie Oker
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Natalie Oker has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
P. Herman
Service d'ORL et Chirurgie de la Face et du Cou, Hôpital Lariboisière, Aphp, 2, rue Ambroise Paré, Paris Cedex 10, France
3 shared publicationsP. Tran Ba Huy
3 shared publicationsA. Mediouni
Service de médecine nucléaire, hôpital Lariboisière (Assistance Publique-Hôpitaux de Paris), 2, rue Ambroise-Paré, 75010 Paris, France
2 shared publications- Damien Bresson
Neurosurgery Department, Hôpital Lariboisière, Université Paris VII, Paris, France
2 shared publications - E. Sauvaget
Hôpital Lariboisière, AP-HP
2 shared publications M. Duet
Service de médecine nucléaire, hôpital Lariboisière (Assistance Publique-Hôpitaux de Paris), 2, rue Ambroise-Paré, 75010 Paris, France; Université Paris-Diderot Paris-7, 75205 Paris cedex 13, France
2 shared publications
Latest Publications
- 1 May 2019
- Published by Elsevier in Journal of Voice
- Vol. 33 (3) , 357-362
Bamboo Nodes on a Series of 15 Patients: Vocal Fold Lesion as a Sign of Autoimmune Disease and Microphonotrauma
- 1 May 2019
- Published by Elsevier in Journal of Voice
- Vol. 33 (3) , 357-362
Bamboo Nodes on a Series of 15 Patients: Vocal Fold Lesion as a Sign of Autoimmune Disease and Microphonotrauma
- 11 November 2017
- Published by Wiley in Head & Neck
- Vol. 40 (1) , 126-136
Ethmoidal adenocarcinoma treated by exclusive endoscopic approach: Focus on learning curve and modification of management
Background: The purpose of this study was to investigate the outcome and recurrences for ethmoidal adenocarcinomas treated by exclusive endoscopic surgery in curative intent and investigate the role of the learning curve.Methods: We conducted a single‐center retrospective study, including 60 patients separated in 2 groups (2002‐2011 n = 28 and 2012‐2015 n = 32).Results: The global survival rate at 5 years was 72.6%, and the global and local recurrence rates were 21.6% and 13.3%, respectively. The learning curve had significant impact on global survival at 2 years (93.8% vs 77.8%) and on overall and local recurrences, despite the higher rate of T4 classifications in the latter group. This learning curve could be explained by the evolution toward large endoscopic resection, bilateral, with resection of the cribriform plate, and eventually medial maxillectomy, and started on the healthy side.Conclusion: For selected cases, exclusive endoscopic resection of ethmoid adenocarcinoma achieves results at least as good as craniofacial resection when performed by an experienced cranial base team and including a large endoscopic resection.
- 11 November 2017
- Published by Wiley in Head & Neck
- Vol. 40 (1) , 126-136
Ethmoidal adenocarcinoma treated by exclusive endoscopic approach: Focus on learning curve and modification of management
Background: The purpose of this study was to investigate the outcome and recurrences for ethmoidal adenocarcinomas treated by exclusive endoscopic surgery in curative intent and investigate the role of the learning curve.Methods: We conducted a single‐center retrospective study, including 60 patients separated in 2 groups (2002‐2011 n = 28 and 2012‐2015 n = 32).Results: The global survival rate at 5 years was 72.6%, and the global and local recurrence rates were 21.6% and 13.3%, respectively. The learning curve had significant impact on global survival at 2 years (93.8% vs 77.8%) and on overall and local recurrences, despite the higher rate of T4 classifications in the latter group. This learning curve could be explained by the evolution toward large endoscopic resection, bilateral, with resection of the cribriform plate, and eventually medial maxillectomy, and started on the healthy side.Conclusion: For selected cases, exclusive endoscopic resection of ethmoid adenocarcinoma achieves results at least as good as craniofacial resection when performed by an experienced cranial base team and including a large endoscopic resection.
- Open Access
- 25 October 2016
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (50) , 82580-82593
Stimulation of the toll-like receptor 3 promotes metabolic reprogramming in head and neck carcinoma cells
Stimulation of the toll-like receptor 3 promotes metabolic reprogramming in head and neck carcinoma cells
- 25 October 2016
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (50) , 82580-82593
Open AccessStimulation of the toll-like receptor 3 promotes metabolic reprogramming in head and neck carcinoma cells
Stimulation of the toll-like receptor 3 promotes metabolic reprogramming in head and neck carcinoma cells
- 17 August 2016
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 274 (1) , 305-310
Outcomes of endoscopic ethmoidectomy performed on a day-case basis: a prospective bi-centric study
Evaluation of endoscopic ethmoidectomy performed as a day-case in terms of security, quality, and satisfaction of the patient. This prospective observatory bi-centric study over 1 year included 74 patients undergoing an ethmoidectomy respecting the eligibility criteria of ambulatory care. We recorded patients’ demographic data, operative details, satisfaction, postoperative course, and follow-up results. Nasal symptoms were evaluated by SNOT-22 on preoperative appointment and postoperatively at D30. No non-absorbable nasal packing was used, eventually in the case of preoperative-bleeding absorbable gelatine packing. The postoperative follow-up took place at D1 by phone call and at D10 and D30 to assess complications, Visual Analogue Scale, and state of ethmoidal corridors by endoscopic exam. Patients benefited of bilateral ethmoidectomy in 82.4 % cases associated with septoplasty in 42 %. The majority (95 %) was discharged on the same day. Only one patient had bleeding at D0 and was kept in standard hospitalization, such as three other patients for medical or organizational reasons not related to surgery. At D1, 23 % described postoperative light bleeding but needed no revisit and pain was estimated at 1.3 (VAS). No readmission was observed, and no major complication was noted. SNOT-22 decreased successfully by 56 %, statistically related to postoperative treatment of corticosteroids and in the case of Samter triad. 97 % of patients were satisfied of the ambulatory care. These results suggest that within an experienced and dedicated day-case medical and paramedical team, ethmoidectomy can be safely performed on a day-case basis with high quality of taking care and satisfaction of patients.
- 17 August 2016
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 274 (1) , 305-310
Outcomes of endoscopic ethmoidectomy performed on a day-case basis: a prospective bi-centric study
Evaluation of endoscopic ethmoidectomy performed as a day-case in terms of security, quality, and satisfaction of the patient. This prospective observatory bi-centric study over 1 year included 74 patients undergoing an ethmoidectomy respecting the eligibility criteria of ambulatory care. We recorded patients’ demographic data, operative details, satisfaction, postoperative course, and follow-up results. Nasal symptoms were evaluated by SNOT-22 on preoperative appointment and postoperatively at D30. No non-absorbable nasal packing was used, eventually in the case of preoperative-bleeding absorbable gelatine packing. The postoperative follow-up took place at D1 by phone call and at D10 and D30 to assess complications, Visual Analogue Scale, and state of ethmoidal corridors by endoscopic exam. Patients benefited of bilateral ethmoidectomy in 82.4 % cases associated with septoplasty in 42 %. The majority (95 %) was discharged on the same day. Only one patient had bleeding at D0 and was kept in standard hospitalization, such as three other patients for medical or organizational reasons not related to surgery. At D1, 23 % described postoperative light bleeding but needed no revisit and pain was estimated at 1.3 (VAS). No readmission was observed, and no major complication was noted. SNOT-22 decreased successfully by 56 %, statistically related to postoperative treatment of corticosteroids and in the case of Samter triad. 97 % of patients were satisfied of the ambulatory care. These results suggest that within an experienced and dedicated day-case medical and paramedical team, ethmoidectomy can be safely performed on a day-case basis with high quality of taking care and satisfaction of patients.
- 1 June 2014
- Published by Elsevier in European Annals of Otorhinolaryngology, Head and Neck Diseases
- Vol. 131 (3) , 159-166
Malignant head/neck paragangliomas. Comparative Study
- 1 June 2014
- Published by Elsevier in European Annals of Otorhinolaryngology, Head and Neck Diseases
- Vol. 131 (3) , 159-166
Malignant head/neck paragangliomas. Comparative Study
- 16 April 2014
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 271 (12) , 3223-3232
Radionecrosis of the frontal lobe as a consequence of malignant ethmoid tumor management: incidence, diagnosis, risk factors, prevention and management
Malignant ethmoid tumors are treated by surgery followed by radiotherapy. This study aimed to evaluate the incidence, risk factors and outcome of radionecrosis of frontal lobe and determine preventive measures. Retrospective study of ethmoid malignancies treated from 2000 to 2011. All patients underwent surgery with/without anterior skull base resection using endoscopic or external approaches followed by irradiation (mean dose 64 Gy). Median follow-up was 50 months. Eight of 50 patients (16 %) presented with fronto-basal radionecrosis, connected to duraplasty, with a latent interval of 18.5 months. Although asymptomatic in six, radionecrosis triggered seizures and required surgery in two cases. Survival was not impacted. Risk factors included dyslipidemia, occurrence of epilepsy and dural resection. Radionecrosis may result from the combination of anterior skull base resection and radiotherapy for the treatment of ethmoid malignancies. Preventive measures rely on improving the duraplasty and optimization of the Gy-dose delivery.
- 16 April 2014
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 271 (12) , 3223-3232
Radionecrosis of the frontal lobe as a consequence of malignant ethmoid tumor management: incidence, diagnosis, risk factors, prevention and management
Malignant ethmoid tumors are treated by surgery followed by radiotherapy. This study aimed to evaluate the incidence, risk factors and outcome of radionecrosis of frontal lobe and determine preventive measures. Retrospective study of ethmoid malignancies treated from 2000 to 2011. All patients underwent surgery with/without anterior skull base resection using endoscopic or external approaches followed by irradiation (mean dose 64 Gy). Median follow-up was 50 months. Eight of 50 patients (16 %) presented with fronto-basal radionecrosis, connected to duraplasty, with a latent interval of 18.5 months. Although asymptomatic in six, radionecrosis triggered seizures and required surgery in two cases. Survival was not impacted. Risk factors included dyslipidemia, occurrence of epilepsy and dural resection. Radionecrosis may result from the combination of anterior skull base resection and radiotherapy for the treatment of ethmoid malignancies. Preventive measures rely on improving the duraplasty and optimization of the Gy-dose delivery.
- 1 October 2012
- Published by Elsevier in Annales françaises d'Oto-rhino-laryngologie et de Pathologie Cervico-faciale
- Vol. 129 (4) , A4-A5
Paragangliomes malins de la tête et du cou. Analyse de 11 cas
- 1 October 2012
- Published by Elsevier in Annales françaises d'Oto-rhino-laryngologie et de Pathologie Cervico-faciale
- Vol. 129 (4) , A4-A5
Paragangliomes malins de la tête et du cou. Analyse de 11 cas
- 31 October 2009
- Published by Elsevier in International Journal of Pediatric Otorhinolaryngology
- Vol. 73 (10) , 1470-1473
Bilateral implantation in children with cochleovestibular nerve hypoplasia
- 31 October 2009
- Published by Elsevier in International Journal of Pediatric Otorhinolaryngology
- Vol. 73 (10) , 1470-1473
Bilateral implantation in children with cochleovestibular nerve hypoplasia